MyAverix Finance MyAverix Finance

SHG · General

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707)

Diversified

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) is listed on SHG in the General sector. Industry: Diversified. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 603707

P/E ratio
18.00

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) — FAQ

What is 603707's P/E ratio?

The price-to-earnings (P/E) ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) is 18.00 (data as of 2026-03-24).

Does Nanjing King-friend Biochemical Pharmaceutical Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707). Check the MyAverix Finance app for the latest dividend data.

What sector is Nanjing King-friend Biochemical Pharmaceutical Co Ltd in?

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) is classified in the General sector (Diversified industry).

What exchange is 603707 listed on?

603707 is listed on SHG.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play